ACC 2024 | IVUS-DCB

Drug-coated balloons (DCB) have proven to be effective in the treatment of femoropopliteal pathology, although they entail complications such as recoil, residual stenosis, and dissection.

ACC 2024

Their outcomes could be improved through proper and enhanced vessel preparation, both before and after the procedure. Intravascular ultrasound (IVUS) offers the advantage of characterizing plaque and assessing vessel diameter.

The aim of this study was to compare IVUS-guided angioplasty vs. conventional angiography in DCB (IN.PACT, Medtronic) treatment of femoropopliteal disease. Researchers included a total of 237 patients from 7 centers in Korea; these subjects were randomized to IVUS (n=119) and angiography (n=118). The primary endpoint was primary patency (PP) at 12 months.

The average age was 69 years; 85.7% of patients were men, 74.8% had claudication, and the rest had critical limb ischemia. Regarding characteristics, most lesions were TASC II C/D (67.2%).

Read also: ACC 2024 | SMART Trial: Self-Expanding or Balloon-Expandable TAVR in Patients with Small Aortic Annulus.

Technical success was achieved in 76.5% of IVUS patients and 61% of those undergoing angiography. Post-procedure ankle-brachial index (ABI) was 0.99 and 0.93, respectively. When evaluating PP, better outcomes were observed in the IVUS arm (hazard ratio [HR], 0.46; 95% confidence interval [CI], 0.25-0.85; Log-rank P= 0.01). Additionally, considering secondary events, IVUS-guided treatment showed better results in terms of revascularization-free vessel (HR, 0.41; 95% CI, 0.19-0.90; Log-rank P= 0.03) and sustained clinical improvement (HR, 0.45; 95% CI, 0.23-0.86; Log-rank P=0.02).

In conclusion, IVUS guidance significantly improved DCB treatment outcomes in femoropopliteal disease, with better primary patency, greater freedom from new revascularization, and clinical improvement at 12 months.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Comparación de angioplastia dirigida por IVUS vs dirigido por angiografía en el tratamiento con balón con drogas para territorio femoropoplíteo. 

Reference: Presentado por Dr. Young-Guk Ko en ACC.24 Late-Breaking Clinical Trials, 6-8 de abril, Atlanta.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...